Cleared Traditional

K131424 - MIPLATFORM MEDICAL IMAGING SUITE

K131424 is the FDA 510(k) clearance for MIPLATFORM MEDICAL IMAGING SUITE by Hinacom Software and Technology, Ltd.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 56-day FDA review.

K131424 · Hinacom Software and Technology, Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
56d
Days
Class 2
Risk

K131424 is an FDA 510(k) clearance for the MIPLATFORM MEDICAL IMAGING SUITE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Hinacom Software and Technology, Ltd. (Beijing, CN). The FDA issued a Cleared decision on July 12, 2013 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Hinacom Software and Technology, Ltd. devices

Submission Details

510(k) Number K131424 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 17, 2013
Decision Date July 12, 2013
Days to Decision 56 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 107d · This submission: 56d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1097
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K131424.
QLAB QUANTIFICATION SOFTWARE
K132165 · Philips Ultrasound, Inc. · Aug 2013
ULTRAEXTEND USWS-900A V2.1 AND V3.1
K131822 · Toshiba America Medical Systems, In.C · Jul 2013
ESIE APPS SUITE
K132062 · Siemens Medical Solutions USA, Inc. · Jul 2013
CODIAGNOSTIX IMPLANT PLANNING SOFTWARE
K130724 · Straumann USA · Jun 2013
SYNAPSE 3D LUNG AND ABDOMEN ANALYSIS
K130542 · Fujifilm Medical System U.S.A., Inc. · Jun 2013
MR PERMEABILITY
K130278 · Philips Medical Systems Nederland B.V. · May 2013